Epigeneres Biotech
Advanced Genetic Therapeutics
Advanced Genetic Therapeutics
Epigeneres Biotech is a leading biotechnology company based in India, established in 2012. The startup focuses on discovering, developing, manufacturing, and commercializing molecular medicines and nutrigenomic formulations for the treatment and prevention of serious medical conditions such as cancer and diseases of ageing. Notably, they have co-developed a cancer prognostic and diagnostic technology with Singapore-based Tzar Labs, and hold the sole license for this technology in India. In their latest funding round, Epigeneres Biotech secured a substantial $6.00M Series B investment on 08 November 2021. The investors included Kotak Investment Advisors and Nimesh Kampani, signaling confidence in the company's potential and innovation in the biotechnology and healthcare sectors. With their slogan "Advanced Genetic Therapeutics", Epigeneres Biotech is positioned to make a significant impact in the field of genetic medicine and personalized healthcare.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | $6.00M | 2 |
|
08 Nov 2021 |
No recent news or press coverage available for Epigeneres Biotech .
We care about your data, and we'd love to use cookies make your experience better.